https://www.selleckchem.com/pr....oducts/pf-06463922.h
To describe patients who developed partial or complete punctal closure after the use of topical netarsudil in the treatment of glaucoma, with documented reversal of symptoms on drug cessation. This is a retrospective, single-center case series including patients treated with topical netarsudil who were documented to have developed punctal disease ipsilateral to the eye(s) being treated. A literature review was also performed to identify other similar reports. A total of 10 patients were included in the study. Six patients developed
Like
Comment
Share
